Research Advance on Biosynthesis of Aromatic Amino Acids and  Their Derivatives

doi:10.13560/j.cnki.biotech.bull.1985.2017.01.003

Abstract

Abstract: Bioengineering has been used to produce various of value-added products including fine chemicals,bulk chemicals,pharmaceuticals and nutraceuticals using sustainable materials. Synthetic biology is the foundation of bioengineering which combined functional genomics,computational biology with system biology to createnovel products and optimize bioprocess. In the past decades,many powerful tools developed from synthetic biology has been used in microorganisms,plants and animals. In this review,we summarize the synthesis of aromatic amino acids and its derivatives in microorganisms and review the recent advances in bio-production of value-added chemicals using synthetic biology.

Key words: synthetic biology, aromaticacids, flavonoids, organicacids, naturalproducts

SHEN Xiao-lin, YUAN Qi-peng. Research Advance on Biosynthesis of Aromatic Amino Acids and Their Derivatives[J]. Biotechnology Bulletin, 2017, 33(1): 24-34.

References

[1] Jullessona D, Davida F, Pflegerb B, et al. Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals[J]. Biotechnology Advances, 2015, 33：1395-1402.
[2] Ro DK, Paradise EM, Ouellet M, et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast[J]. Nature, 2006, 440：940-943.
[3] Paddon CJ, Westfall PJ, Pitera DJ, et al. High-level semi-synthetic production of the potent antimalarial artemisinin[J]. Nature, 2013, 496：528-532.
[4] Krivoruchko A, Nielsen J. Production of natural products through metabolic engineering of Saccharomyces cerevisiae[J]. Current Opinion in Biotechnology, 2015, 35：7-15.
[5] Sun X, Shen, X, Jain R, et al. Synthesis of chemicals by metabolic engineering of microbes[J]. Chemical Society Reviews, 2015, 44：3760-3785.
[6] Lütke-Eversloh T, Stephanopoulos G. L-tyrosine production by deregulated strains of Escherichia coli[J]. Applied Microbiology and Biotechnology, 2007, 75：103-110.
[7] Rodriguez A, Kildegaard KR, Li M, et al. Establishment of a yeast platform strain for production of p-coumaric acid through metabolic engineering of aromatic amino acid biosynthesis[J]. Metabolic Engineering, 2015, 31：181-188.
[8] Tatarko M, Romeo T. Disruption of a global regulatory gene to enhance central carbon flux into phenylalanine biosynthesis in Escherichia coli[J]. Current Microbiology, 2001, 43：26-32.
[9] Ikeda M. Towards bacterial strains overproducing L-tryptophan and other aromatics by metabolic engineering[J]. Applied Microbiology and Biotechnology, 2006, 69：615-626.
[10] Patnaik R, Zolandz RR, Green DA, et al. L-Tyrosine production by recombinant Escherichia coli：Fermentation optimization and recovery[J]. Biotechnology and Bioengineering, 2008, 99：741-752.
[11] Konstantinov KB, Nishio N, Seki T, et al. Physiologically motivated strategies for control of the fed-batch cultivation of recombinant Escherichia coli for phenylalanine production[J]. Journal of Fermentation and Bioengineering, 1991, 71：350-355.
[12] Ikeda M, Katsumata R. Transport of aromatic amino acids and its influence on overproduction of the amino acids in Corynebacterium glutamicum[J]. Journal of Fermentation and Bioengineering, 1994, 78：420-425.
[13] Wehrmann A, Morakkabati S, Krämer R, et al. Functional analysis of sequences adjacent to dapE of Corynebacterium glutamicum reveals the presence of aroP, which encodes the aromatic amino acid transporter[J]. Journal of Bacteriology, 1995, 177：5991-5993.
[14] Hayat S, Ali B, Ahmad A. Salicylic acid：biosynthesis, metabolism and physiological role in plants[M]. Salicylic acid：A plant hormone：Springer, 2007：1-14.
[15] Steele K, Shirodaria P, O’HARE M, et al. Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts：effectiveness and mode of action[J]. British Journal of Dermatology, 1988, 118：537-544.
[16] Tounekti T, Hernández I, Munné-Bosch S. Salicylic acid biosynthesis and role in modulating terpenoid and flavonoid metabolism in plant responses to abiotic stress[M]. Salicylic acid：Springer, 2013：141-162.
[17] Lin Y, Sun X, Yuan Q, et al. Extending shikimate pathway for the production of muconic acid and its precursor salicylic acid in Escherichia coli[J]. Metabolic Engineering, 2014, 23：62-69.
[18] Noda S, Shirai T, Oyama S, et al. Metabolic design of a platform Escherichia coli strain producing various chorismate derivatives[J]. Metabolic Engineering, 2016, 33：119-129.
[19] Draths KM, Frost JW. Environmentally compatible synthesis of adipic acid from D-glucose[J]. Journal of the American Chemical Society, 1994, 116：399-400.
[20] Curran KA, Leavitt JM, Karim AS, et al. Metabolic engineering of muconic acid production in Saccharomyces cerevisiae[J]. Metabolic Engineering, 2013, 15：55-66.
[21] Sun X, Lin Y, Huang Q, et al. A novel muconic acid biosynthesis approach by shunting tryptophan biosynthesis via anthranilate[J]. Applied and Environmental Microbiology, 2013, 79：4024-4030.
[22] Sun X, Lin Y, Yuan Q, et al. Biological production of muconic acid via a prokaryotic 2, 3-dihydroxybenzoic acid decarboxylase[J]. ChemSusChem, 2014, 7：2478-2481.
[23] Zhang H, Pereira B, Li Z, et al. Engineering Escherichia coli coculture systems for the production of biochemical products[J]. Proceedings of the National Academy of Sciences, 2015, 112：8266-8271.
[24] Johnson CW, Salvachúa D, Khanna P, et al. Enhancing muconic acid production from glucose and lignin-derived aromatic compounds via increased protocatechuate decarboxylase activity[J]. Metabolic Engineering Communications, 2016, 3：111-119.
[25] Skjoedt ML, Snoek T, Kildegaard KR, et al. Engineering prokaryotic transcriptional activators as metabolite biosensors in yeast[J]. Nature Chemical Biology, 2016, 12：951-958.
[26] Vogt T. Phenylpropanoid biosynthesis[J]. Molecular Plant, 2010, 3：2-20.
[27] Luo Y, Li B, Liu D, et al. Engineered biosynthesis of natural products in heterologous hosts[J]. Chemical Society Reviews, 2015, 44：5265-5290.
[28] Wang J, Guleria S, Koffas MAG, et al. Microbial production of value-added nutraceuticals[J]. Current Opinion in Biotechnology, 2016, 37：97-104.
[29] Ro DK, Douglas CJ. Reconstitution of the entry point of plant phenylpropanoid metabolism in yeast（Saccharomyces cerevisiae）IMPLICATIONS FOR CONTROL OF METABOLIC FLUX INTO THE PHENYLPROPANOID PATHWAY[J]. Journal of Biological Chemistry, 2004, 279：2600-2607.
[30] Vannelli T, Qi W, Sweigard J, et al. Production of p-hydroxycinna-mic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi[J]. Metabolic Engineering, 2007, 9：142-151.
[31] Kang SY, Choi O, Lee JK, et al. Artificial biosynthesis of phenylpr-opanoic acids in a tyrosine overproducing Escherichia coli strain [J]. Microbial Cell Factories, 2012, 11：1.
[32] Prasad NR, Karthikeyan A, Karthikeyan S, et al. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line[J]. Molecular and Cellular Biochemistry, 2011, 349：11-19.
[33] Chao P, Hsu C, Yin M. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice[J]. Nutrition & Metabolism, 2009, 6：1.
[34] Olthof MR, Hollman PCH, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans[J]. The Journal of Nutrition, 2001, 131：66-71.
[35] Kim JH, Campbell BC, Yu J, et al. Examination of fungal stress response genes using Saccharomyces cerevisiae as a model system：targeting genes affecting aflatoxin biosynthesis by Aspergillus flavus link[J]. Applied Microbiology and Biotechnology, 2005, 67：807-815.
[36] Kim YH, Kwon TW, Yang HJ, et al. Gene engineering, purification, crystallization and preliminary X-ray diffraction of cytochrome P450 p-coumarate-3-hydroxylase（C3H）, the Arabidopsis membrane protein[J]. Protein Expression and Purification, 2011, 79：149-155.
[37] Berner M, Krug D, Bihlmaier C, et al. Genes and enzymes involved in caffeic acid biosynthesis in the actinomycete Saccharothrix espanaensis[J]. Journal of Bacteriology, 2006, 188：2666-2673.
[38] Louie TM, Xie XS, Xun L. Coordinated production and utilization of FADH2 by NAD（P）H-flavin oxidoreductase and 4-hydroxyphenylacetate 3-monooxygenase[J]. Biochemistry, 2003, 42：7509-7517.
[39] Soulimane T, O’Kane SR, Kolaj O. Isolation and purification of Thermus thermophilus HpaB by a crystallization approach[J]. Acta Crystallographica Section F：Structural Biology and Crystallization Communications, 2010, 66：352-356.
[40] Thotsaporn K, Sucharitakul J, Wongratana J, et al. Cloning and expression of p-hydroxyphenylacetate 3-hydroxylase from Acinetobacter baumannii：evidence of the divergence of enzymes in the class of two-protein component aromatic hydroxylases[J]. Biochimica et Biophysica Acta（BBA）-Gene Structure and Expression, 2004, 1680：60-66.
[41] Arias-Barrau E, Sandoval Á, Naharro G, et al. A two-component hydroxylase involved in the assimilation of 3-hydroxyphenyl acetate in Pseudomonas putida[J]. Journal of Biological Chemistry, 2005, 280：26435-26447.
[42] Furuya T, Kino K. Catalytic activity of the two-component flavin-dependent monooxygenase from Pseudomonas aeruginosa toward cinnamic acid derivatives[J]. Applied Microbiology and Biotechnology, 2014, 98：1145-1154.
[43] Huang Q, Lin Y, Yan Y. Caffeic acid production enhancement by engineering a phenylalanine over-producing Escherichia coli strain[J]. Biotechnology and Bioengineering, 2013, 110：3188-3196.
[44] Sun J, Lin Y, Shen X, et al. Aerobic biosynthesis of hydrocinnamic acids in Escherichia coli with a strictly oxygen-sensitive enoate reductase[J]. Metabolic Engineering, 2016, 35：75-82.
[45] Vargas-Tah A, Martínez LM, Hernández-Chávez G, et al. Production of cinnamic and p-hydroxycinnamic acid from sugar mixtures with engineered Escherichia coli[J]. Microbial Cell Factories, 2015, 14：1.
[46] Yao Y, Wang C, Qiao J, et al. Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway[J]. Metabolic Engineering, 2013, 19：79-87.
[47] Bloch SE, Schmidt-Dannert C. Construction of a chimeric biosynthetic pathway for the de novo biosynthesis of rosmarinic acid in Escherichia coli[J]. ChemBioChem, 2014, 15：2393-2401.
[48] Kim BG, Jung WD, Mok H, et al. Production of hydroxycinnamoyl-shikimates and chlorogenic acid in Escherichia coli：production of hydroxycinnamic acid conjugates[J]. Microbial Cell Factories, 2013, 12：1.
[49] Yan Y, Kohli A, Koffas MAG. Biosynthesis of natural flavanones in Saccharomyces cerevisiae[J]. Applied and Environmental Microbiology, 2005, 71：5610-5613.
[50] Miyahisa I, Kaneko M, Funa N, et al. Efficient production of（2S）-flavanones by Escherichia coli containing an artificial biosynthetic gene cluster[J]. Applied Microbiology and Biotechnology, 2005, 68：498-504.
[51] Koopman F, Beekwilder J, Crimi B, et al. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae[J]. Microbial Cell Factories, 2012, 11：1.
[52] Leonard E, Yan Y, Fowler ZL, et al. Strain improvement of recombinant Escherichia coli for efficient production of plant flavonoids[J]. Molecular Pharmaceutics, 2008, 5：257-265.
[53] Leonard E, Lim KH, Saw PN, et al. Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli[J]. Applied and Environmental Microbiology, 2007, 73：3877-3886.
[54] Wu J, Yu O, Du G, et al. Fine-tuning of the fatty acid pathway by synthetic antisense RNA for enhanced（2S）-naringenin production from L-tyrosine inEscherichia coli[J]. Applied and Environmental Microbiology, 2014, 80：7283-7292.
[55] Yang Y, Lin Y, Li L, et al. Regulating malonyl-CoA metabolism via synthetic antisense RNAs for enhanced biosynthesis of natural products[J]. Metabolic Engineering, 2015, 29：217-226.
[56] Wu J, Zhou T, Du G, et al. Modular optimization of heterologous pathways for de novo synthesis of（2S）-naringenin in Escherichia coli[J]. PLoS One, 2014, 9：e101492.
[57] Lin Y, Shen X, Yuan Q, et al. Microbial biosynthesis of the anticoagulant precursor 4-hydroxycoumarin[J]. Nature Communications, 2013, 4：2603.
[58] Lin Y, Yan Y. Biotechnological production of plant-specific hydroxylated phenylpropanoids[J]. Biotechnology and Bioengineering, 2014, 111：1895-1899.
[59] Murray RDH, Méndez J, Brown SA. The natura, coumarins：Occurrence, Chemistry and Biochemistry[M]. John Wiley & Sons, 1982.
[60] Lin Y, Sun X, Yuan Q, et al. Combinatorial biosynthesis of plant-specific coumarins in bacteria[J]. Metabolic Engineering, 2013, 18：69-77.
[61] Furuya T, Kino K. Regioselective synthesis of piceatannol from resveratrol：Catalysis by two-component flavin-dependent monooxygenase HpaBC in whole cells[J]. Tetrahedron Letters, 2014, 55：2853-2855.
[62] Jones JA, Collins SM, Vernacchio VR, et al. Optimization of naringenin and p-coumaric acid hydroxylation using the native E. coli hydroxylase complex, HpaBC[J]. Biotechnology Progress, 2016, 32（1）：21-25.
[63] Carrizzo A, Forte M, Damato A, et al. Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases[J]. Food and Chemical Toxicology, 2013, 61：215-226.
[64] Hsu S, Huang S, Chen A, et al. Resveratrol increases anti-aging Klotho gene expression via the activating transcription factor 3/c-Jun complex-mediated signaling pathway[J]. The International Journal of Biochemistry & Cell Biology, 2014, 53：361-371.
[65] Lissa D, Senovilla L, Rello-Varona S, et al. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention[J]. Proceedings of the National Academy of Sciences, 2014, 111：3020-3025.
[66] Beekwilder J, Wolswinkel R, Jonker H, et al. Production of resveratrol in recombinant microorganisms[J]. Applied and Environmental Microbiology, 2006, 72：5670-5672.
[67] Zhang Y, Li S, Li J, et al. Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells[J]. Journal of the American Chemical Society, 2006, 128：13030-13031.
[68] Sydor T, Schaffer S, Boles E. Considerable increase in resveratrol production by recombinant industrial yeast strains with use of rich medium[J]. Applied and Environmental Microbiology, 2010, 76：3361-3363.
[69] Lim CG, Fowler ZL, Hueller T, et al. High-yield resveratrol production in engineered Escherichia coli[J]. Applied and Environmental Microbiology, 2011, 77：3451-3460.
[70] Byerley W, Judd LL, Reimherr FW, et al. 5-Hydroxytryptophan：a review of its antidepressant efficacy and adverse effects[J]. Journal of Clinical Psychopharmacology, 1987, 7：127-137.
[71] Lin Y, Sun X, Yuan Q, et al. Engineering bacterial phenylalanine 4-hydroxylase for microbial synthesis of human neurotransmitter precursor 5-hydroxytryptophan[J]. ACS Synthetic Biology, 2014, 3：497-505.
[72] Sun X, Lin Y, Yuan Q, et al. Precursor-directed biosynthesis of 5-hydroxytryptophan using metabolically engineered E. coli[J]. ACS Synthetic Biology, 2014, 4：554-558.
[73] Han Y, Je JH, Kim SH, et al. Gastrodia elata shows neuroprotective effects via activation of PI3K signaling against oxidative glutamate toxicity in HT22 cells[J]. The American Journal of Chinese Medicine, 2014, 42：1007-1019.
[74] Jung JW, Yoon BH, Oh HR, et al. Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice[J]. Biological and Pharmaceutical Bulletin, 2006, 29：261-265.
[75] Ahn EK, Jeon HJ, Lim EJ, et al. Anti-inflammatory and anti-angiogenic activities of Gastrodia elata Blume[J]. Journal of Ethnopharmacology, 2007, 110：476-482.
[76] Bai Y, Yin H, Bi H, et al. De novo biosynthesis of Gastrodin in Escherichia coli[J]. Metabolic Engineering, 2016, 35：138-147.
[77] Ahmadi MK, Fang L, Moscatello N, et al. E. coli metabolic engineering for gram scale production of a plant-based anti-inflammatory agent[J]. Metabolic Engineering, 2016, 38：382-388.

Research Advance on Biosynthesis of Aromatic Amino Acids and Their Derivatives

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	CHENG Ting, YUAN Shuai, ZHANG Xiao-yuan, LIN Liang-cai, LI Xin, ZHANG Cui-ying. Research Progress in the Regulation of Isobutanol Synthesis Pathway in Saccharomyces cerevisiae [J]. Biotechnology Bulletin, 2023, 39(7): 80-90.
[2]	ZHANG He-chen, YUAN Xin, GAO Jie, WANG Xiao-chen, WANG Hui-juan, LI Yan-min, WANG Li-min, FU Zhen-zhu, LI Bao-yin. Mechanism of Flower Petal Coloration and Molecular Breeding [J]. Biotechnology Bulletin, 2023, 39(5): 23-31.
[3]	MA Fang-fang, LIU Guan-wen, PANG Bing, JIANG Chun-mei, SHI Jun-ling. Strategies of Increasing Flavonoid Production in Engineered Bacteria by Intensifying the Efflux of Flavonoid in Cells [J]. Biotechnology Bulletin, 2023, 39(5): 63-76.
[4]	WANG Xiao-mei, YANG Xiao-wei, LI Hui-shang, HE Wei, XIN Zhu-lin. Development Status of Synthetic Biology in Globe and Its Enlightenment [J]. Biotechnology Bulletin, 2023, 39(2): 292-302.
[5]	CHEN Xiao-lin, LIU Yang-er, XU Wen-tao, GUO Ming-zhang, LIU Hui-lin. Application of Synthetic Biology Based Whole-cell Biosensor Technology in the Rapid Detection of Food Safety [J]. Biotechnology Bulletin, 2023, 39(1): 137-149.
[6]	ZHOU Lin, LIANG Xuan-ming, ZHAO Lei. Biosynthesis of Natural Carotenoids：Progress and Perspective [J]. Biotechnology Bulletin, 2022, 38(7): 119-127.
[7]	DUAN Yue-tong, WANG Peng-nian, ZHANG Chun-bao, LIN Chun-jing. Research Progress in Plant Flavanone-3-hydroxylase Gene [J]. Biotechnology Bulletin, 2022, 38(6): 27-33.
[8]	GUO Xiao-zhen, ZHANG Xue-fu. Analysis of the Development Trend in the Field of Plant Synthetic Biology [J]. Biotechnology Bulletin, 2022, 38(2): 289-296.
[9]	YAO Yu, GU Jia-jun, SUN Chao, SHEN Guo-an, GUO Bao-lin. Advances in Plant Flavonoids UDP-glycosyltransferase [J]. Biotechnology Bulletin, 2022, 38(12): 47-57.
[10]	LUO Ya-fang, ZHU Chun-hua, XIAO Yu-ting, LI Fang-quan, ZHANG Jiang, WANG Yu-shu. Screening and Functional Analysis of UGT Genes Involved in the Flavonoid Biosynthesis of Brassica oleracea var. acephala [J]. Biotechnology Bulletin, 2022, 38(11): 194-201.
[11]	ZHAO Yu-xue, WANG Yun, YU Lu-yao, LIU Jing-jing, SI Jin-ping, ZHANG Xin-feng, ZHANG Lei. Structure and Application of C-glycosyltransferases in Plants [J]. Biotechnology Bulletin, 2022, 38(10): 18-28.
[12]	YE Min, GAO Jiao-qi, ZHOU Yong-jin. Engineering Non-conventional Yeast Cell Factory for the Biosynthesis of Natural Products [J]. Biotechnology Bulletin, 2021, 37(8): 12-24.
[13]	ZHANG Chan, YAO Guang-long, ZHANG Jun-feng, YU Jing, YANG Dong-mei, CHEN Ping, WU You-gen. Research Progress on Patchoulol Molecular Regulation and Synthetic Biology in Pogostemon cablin [J]. Biotechnology Bulletin, 2021, 37(8): 55-64.
[14]	YE Jian-wen, CHEN Jiang-nan, ZHANG Xu, Wu Fu-qing, CHEN Guo-qiang. Dynamic Control：An Efficient Strategy for Metabolically Engineering Microbial Cell Factories [J]. Biotechnology Bulletin, 2020, 36(6): 1-12.
[15]	CHANG Han-wen, ZHENG Xin-ling, LUO Jian-mei, WANG Min, SHEN Yan-bing. Tolerance Elements and Their Application Progress on the Construction of Highly-efficient Microbial Cell Factory [J]. Biotechnology Bulletin, 2020, 36(6): 13-34.